Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?

This study aimed at evaluating anti-Mycobacterium leprae antibody levels in reactional and non-reactional leprosy patients at the time of diagnosis. Clinical data and serum samples of 224 patients diagnosed between 2009/2010, were collected in the municipality of Rondon ópolis-MTBR. Quantification of anti-phenolic glycolipid-1 (PGL-1) IgM antibodies of M.

Source: Diagnostic Microbiology and Infectious Disease - March 15, 2018 Category: Microbiology Authors: Amanda Carreira Devides, Patricia Sammarco Rosa, Andr éa de Faria Fernandes Belone, Neusa Maria Broch Coelho, Somei Ura, Eliane Aparecida Silva Source Type: research